134 related articles for article (PubMed ID: 3105913)
41. Acute nifedipine withdrawal: consequences of preoperative and late cessation of therapy in patients with prior unstable angina.
Gottlieb SO; Ouyang P; Achuff SC; Baughman KL; Traill TA; Mellits ED; Weisfeldt ML; Gerstenblith G
J Am Coll Cardiol; 1984 Aug; 4(2):382-8. PubMed ID: 6376596
[TBL] [Abstract][Full Text] [Related]
42. Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trial.
Serruys PW; Arnold AE; Brower RW; de Bono DP; Bokslag M; Lubsen J; Reiber JH; Rutsch WR; Uebis R; Vahanian A
Eur Heart J; 1987 Nov; 8(11):1172-81. PubMed ID: 3121334
[TBL] [Abstract][Full Text] [Related]
43. Spotlight article: thrombolysis in unstable angina: randomized double-blind trial of t-PA and placebo. Circulation 1992;85: 150-7. (Freeman MR, Langer A, Wilson RF, Morgan CD, Armstrong PW.).
Kennedy GT
Heart Lung; 1992; 21(5):502-4. PubMed ID: 1399669
[TBL] [Abstract][Full Text] [Related]
44. Unstable angina. Rational approach to management.
Flaherty JT
Am J Med; 1984 Jun; 76(6A):52-7. PubMed ID: 6146257
[TBL] [Abstract][Full Text] [Related]
45. Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction.
Verstraete M; Bleifeld W; Brower RW; Charbonnier B; Collen D; de Bono DP; Dunning AJ; Lennane RJ; Lubsen J; Mathey DG
Lancet; 1985 Nov; 2(8462):965-9. PubMed ID: 2865502
[TBL] [Abstract][Full Text] [Related]
46. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
[TBL] [Abstract][Full Text] [Related]
47. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
Collen D; Topol EJ; Tiefenbrunn AJ; Gold HK; Weisfeldt ML; Sobel BE; Leinbach RC; Brinker JA; Ludbrook PA; Yasuda I
Circulation; 1984 Dec; 70(6):1012-7. PubMed ID: 6388898
[TBL] [Abstract][Full Text] [Related]
48. Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study.
Karlberg KE; Saldeen T; Wallin R; Henriksson P; Nyquist O; Sylvén C
J Intern Med; 1998 Jan; 243(1):25-31. PubMed ID: 9487328
[TBL] [Abstract][Full Text] [Related]
49. Unstable angina: status of aspirin and other forms of therapy.
Lewis HD
Circulation; 1985 Dec; 72(6 Pt 2):V155-60. PubMed ID: 3905054
[TBL] [Abstract][Full Text] [Related]
50. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
Collen D; Van de Werf F
Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
[TBL] [Abstract][Full Text] [Related]
51. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial.
Circulation; 1993 Jan; 87(1):38-52. PubMed ID: 8419023
[TBL] [Abstract][Full Text] [Related]
52. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Jia XQ; Dong CM; Qin J; Zhang L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
[TBL] [Abstract][Full Text] [Related]
53. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
54. Cardioselective beta-blockade with metoprolol in rest angina: a randomized, double-blind, placebo-controlled, cross-over trial.
Polese A; De Cesare N; Loaldi A; Lundgren B; Savonitto S
Cardiologia; 1989 Apr; 34(4):333-9. PubMed ID: 2667758
[TBL] [Abstract][Full Text] [Related]
55. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
Ohman EM; Kleiman NS; Gacioch G; Worley SJ; Navetta FI; Talley JD; Anderson HV; Ellis SG; Cohen MD; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt MM; Sigmon KN; Califf RM; Krucoff MW; Topol EJ
Circulation; 1997 Feb; 95(4):846-54. PubMed ID: 9054741
[TBL] [Abstract][Full Text] [Related]
56. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
57. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
[TBL] [Abstract][Full Text] [Related]
58. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve.
Cannon RO; Watson RM; Rosing DR; Epstein SE
Am J Cardiol; 1985 Aug; 56(4):242-6. PubMed ID: 4025160
[TBL] [Abstract][Full Text] [Related]
60. Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group.
Haq A; Morgan CD; Wilson RF; Daly PA; Baigrie RS; White CW; Roberts R; Gent M; Armstrong PW
Am J Cardiol; 1993 Aug; 72(5):379-83. PubMed ID: 8352178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
